Skip to main content

Vbi Vaccines Inc CS(VBIV-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Volume

Vbi Vaccines Inc CS

160 Second Street Floor 3
Cambridge MA 02142 USA
P: 617-830-3031
http://www.vbivaccines.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    VBI Vaccines Inc. is a biopharmaceutical company developing novel technologies to expand vaccine protection. The company's eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines which closely mimic the target virus. Its lead eVLP asset is a prophylactic cytomegalovirus vaccine. Its second platform is a thermostable technology that enables the development of vaccines and biologics. VBI Vaccines Inc., formerly known as SciVac Therapeutics, Inc., is headquartered in Cambridge, MA.

    Key Executives

    NameTitle
    Avi MazaltovGeneral Manager, Subsidiary/Other Corporate Officer
    Jeffrey R. BaxterCEO/Director/President
    David E. AndersonChief Scientific Officer
    Nell BeattieCFO/Director/Other Corporate Officer
    Francisco Diaz-MitomaChief Medical Officer
    John Robert DillmanOther Executive Officer